Works by Hoogeboom, Baukje-Nynke

Results: 7

Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer.

Published in:

Cancer Immunology, Immunotherapy, 2009, v. 58, n. 3, p. 449, doi. 10.1007/s00262-008-0583-5

By:

Leffers, Ninke;
Gooden, Marloes J. M.;
de Jong, Renske A.;
Hoogeboom, Baukje-Nynke;
ten Hoor, Klaske A.;
Hollema, Harry;
Boezen, H. Marieke;
van der Zee, Ate G. J.;
Daemen, Toos;
Nijman, Hans W.

Publication type:

Article

Enhancement of human papilloma virus type 16 E7 specific T cell responses by local invasive procedures in patients with (pre)malignant cervical neoplasia.

Published in:

International Journal of Cancer, 2006, v. 118, n. 10, p. 2529, doi. 10.1002/ijc.21673

By:

Visser, Jeroen;
van Baarle, Debbie;
Hoogeboom, Baukje Nynke;
Reesink, Nathalie;
Klip, Harry;
Schuuring, Ed;
Nijhuis, Esther;
Pawlita, Michael;
Bungener, Laura;
de Vries-Idema, Jacqueline;
Nijman, Hans;
Miedema, Frank;
Daemen, Toos;
van der Zee, Ate

Publication type:

Article

Therapeutic immunization and local low-dose tumor irradiation, a reinforcing combination.

Published in:

International Journal of Cancer, 2014, v. 134, n. 4, p. 859, doi. 10.1002/ijc.28418

By:

Draghiciu, Oana;
Walczak, Mateusz;
Hoogeboom, Baukje Nynke;
Franken, Kees L.M.C.;
Melief, Kees J.M.;
Nijman, Hans W.;
Daemen, Toos

Publication type:

Article

Potentiation of a p53-SLP vaccine by cyclophosphamide in ovarian cancer: A single-arm phase II study.

Published in:

International Journal of Cancer, 2012, v. 131, n. 5, p. E670, doi. 10.1002/ijc.27388

By:

Vermeij, Renee;
Leffers, Ninke;
Hoogeboom, Baukje-Nynke;
Hamming, Ineke L.E.;
Wolf, Rinze;
Reyners, Anna K.L.;
Molmans, Barbara H.W.;
Hollema, Harry;
Bart, Joost;
Drijfhout, Jan W.;
Oostendorp, Jaap;
van der Zee, Ate G.J.;
Melief, Cornelis J.;
van der Burg, Sjoerd H.;
Daemen, Toos;
Nijman, Hans W.

Publication type:

Article

Long-term clinical and immunological effects of p53-SLP® vaccine in patients with ovarian cancer.

Published in:

International Journal of Cancer, 2012, v. 130, n. 1, p. 105, doi. 10.1002/ijc.25980

By:

Leffers, Ninke;
Vermeij, Renee;
Hoogeboom, Baukje-Nynke;
Schulze, Ute R.;
Wolf, Rinze;
Hamming, Ineke E.;
van der Zee, Ate G.;
Melief, Kees J.;
van der Burg, Sjoerd H.;
Daemen, Toos;
Nijman, Hans W.

Publication type:

Article

Immunization with a P53 synthetic long peptide vaccine induces P53-specific immune responses in ovarian cancer patients, a phase II trial.

Published in:

International Journal of Cancer, 2009, v. 125, n. 9, p. 2104, doi. 10.1002/ijc.24597

By:

Leffers, Ninke;
Lambeck, Annechien J.A.;
Gooden, Marloes J.M.;
Hoogeboom, Baukje-Nynke;
Wolf, Rinze;
Hamming, Ineke E.;
Hepkema, Bouke G.;
Willemse, Pax H.B.;
Molmans, Barbara H.W.;
Hollema, Harry;
Drijfhout, Jan W.;
Sluiter, Willem J.;
Valentijn, A. Rob P.M.;
Fathers, Loraine M.;
Oostendorp, Jaap;
van der Zee, Ate G.J.;
Melief, Cornelis J.;
van der Burg, Sjoerd H.;
Daemen, Toos;
Nijman, Hans W.

Publication type:

Article

P53-specific T cell responses in patients with malignant and benign ovarian tumors: Implications for p53 based immunotherapy.

Published in:

International Journal of Cancer, 2007, v. 121, n. 3, p. 606, doi. 10.1002/ijc.22710

By:

Lambeck, Annechien;
Leffers, Ninke;
Hoogeboom, Baukje-Nynke;
Sluiter, Wim;
Hamming, Ineke;
Klip, Harry;
ten Hoor, Klaske;
Esajas, Martha;
van Oven, Magda;
Drijfhout, Jan-Wouter;
Platteel, Inge;
Offringa, Rienk;
Hollema, Harry;
Melief, Kees;
van der Burg, Sjoerd;
van der Zee, Ate;
Daemen, Toos;
Nijman, Hans

Publication type:

Article